CP-866,087 is a novel, potent and selective μ-opioid receptor antagonist with activity to inhibit opioid effects. CP-866,087 has shown promising preclinical efficacy data in disease models associated with alcohol consumption. CP-866,087 has also been used to study female sexual dysfunction[1].
References
[1] Discovery of CP-866,087, a mu opioid receptor antagonist for the treatment of alcohol abuse and dependence
